{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:42Z","timestamp":1781650722149,"version":"3.54.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009550","name":"Universiteit Hasselt","doi-asserted-by":"publisher","award":["21DOC16BOF"],"award-info":[{"award-number":["21DOC16BOF"]}],"id":[{"id":"10.13039\/501100009550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008191","name":"Wings for Life","doi-asserted-by":"publisher","award":["WFL-BE-02\/22"],"award-info":[{"award-number":["WFL-BE-02\/22"]}],"id":[{"id":"10.13039\/100008191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03821-3","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:06:32Z","timestamp":1776830792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhanced MIF\/CD74 axis activity shapes B cell functioning following traumatic spinal cord injury"],"prefix":"10.1186","volume":"23","author":[{"given":"Serina","family":"Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte C. M.","family":"van Laake-Geelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Depreitere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Bamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin M. J.","family":"Cornips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveleen","family":"Buelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diedrik","family":"Peuskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Deckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fraussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"3821_CR1","unstructured":"World Health Organization. Spinal Cord Injury. [updated 16 April 2024; cited 2025]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/spinal-cord-injury."},{"issue":"1","key":"3821_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-021-02337-2","volume":"18","author":"DJ Hellenbrand","year":"2021","unstructured":"Hellenbrand DJ, Quinn CM, Piper ZJ, Morehouse CN, Fixel JA, Hanna AS. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration. J Neuroinflammation. 2021;18(1):284.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3821_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/exnr.1998.6785","volume":"151","author":"SL Carlson","year":"1998","unstructured":"Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol. 1998;151(1):77\u201388.","journal-title":"Exp Neurol"},{"issue":"Pt 12","key":"3821_CR4","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1093\/brain\/awl296","volume":"129","author":"JC Fleming","year":"2006","unstructured":"Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, et al. The cellular inflammatory response in human spinal cords after injury. Brain. 2006;129(Pt 12):3249\u201369.","journal-title":"Brain"},{"issue":"3","key":"3821_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S","volume":"377","author":"PG Popovich","year":"1997","unstructured":"Popovich PG, Wei P, Stokes BT. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol. 1997;377(3):443\u201364.","journal-title":"J Comp Neurol"},{"issue":"1","key":"3821_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12974-022-02627-3","volume":"19","author":"ES Fisher","year":"2022","unstructured":"Fisher ES, Amarante MA, Lowry N, Lotz S, Farjood F, Temple S, et al. Single cell profiling of CD45(+) spinal cord cells reveals microglial and B cell heterogeneity and crosstalk following spinal cord injury. J Neuroinflammation. 2022;19(1):266.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3821_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1471-4159.2006.04147.x","volume":"99","author":"DP Ankeny","year":"2006","unstructured":"Ankeny DP, Lucin KM, Sanders VM, McGaughy VM, Popovich PG. Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis. J Neurochem. 2006;99(4):1073\u201387.","journal-title":"J Neurochem"},{"issue":"10","key":"3821_CR8","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1172\/JCI39780","volume":"119","author":"DP Ankeny","year":"2009","unstructured":"Ankeny DP, Guan Z, Popovich PG. B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice. J Clin Invest. 2009;119(10):2990\u20139.","journal-title":"J Clin Invest"},{"issue":"1","key":"3821_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12974-025-03338-1","volume":"22","author":"R Kumari","year":"2025","unstructured":"Kumari R, Hammers GV, Hammons RH, Stewart AN, MacLean SM, Niedzielko T, et al. Cross-species comparisons between pigs and mice reveal conserved sex-specific intraspinal inflammatory responses after spinal cord injury. J Neuroinflammation. 2025;22(1):16.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"3821_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/brain\/awaa360","volume":"144","author":"T Zrzavy","year":"2021","unstructured":"Zrzavy T, Schwaiger C, Wimmer I, Berger T, Bauer J, Butovsky O, et al. Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury. Brain. 2021;144(1):144\u201361.","journal-title":"Brain"},{"key":"3821_CR11","doi-asserted-by":"crossref","unstructured":"Schwab JM, Haider C, Kopp MA, Zrzavy T, Endmayr V, Ricken G, et al. Lesional antibody synthesis and complement deposition associate with de novo antineuronal antibody synthesis after spinal cord injury. Neurol Neuroimmunol Neuroinflamm. 2023;10(3):e200099.","DOI":"10.1212\/NXI.0000000000200099"},{"issue":"6","key":"3821_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/08977150260139129","volume":"19","author":"KC Hayes","year":"2002","unstructured":"Hayes KC, Hull TC, Delaney GA, Potter PJ, Sequeira KA, Campbell K, et al. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J Neurotrauma. 2002;19(6):753\u201361.","journal-title":"J Neurotrauma"},{"issue":"11","key":"3821_CR13","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.apmr.2007.08.004","volume":"88","author":"AL Davies","year":"2007","unstructured":"Davies AL, Hayes KC, Dekaban GA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil. 2007;88(11):1384\u201393.","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"3821_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s00586-011-2060-7","volume":"21","author":"D Zajarias-Fainsod","year":"2012","unstructured":"Zajarias-Fainsod D, Carrillo-Ruiz J, Mestre H, Grijalva I, Madrazo I, Ibarra A. Autoreactivity against myelin basic protein in patients with chronic paraplegia. Eur Spine J. 2012;21(5):964\u201370.","journal-title":"Eur Spine J"},{"issue":"1","key":"3821_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12974-016-0713-5","volume":"13","author":"I Palmers","year":"2016","unstructured":"Palmers I, Ydens E, Put E, Depreitere B, Bongers-Janssen H, Pickkers P, et al. Antibody profiling identifies novel antigenic targets in spinal cord injury patients. J Neuroinflammation. 2016;13(1):243.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3821_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s13311-016-0446-2","volume":"13","author":"G Casili","year":"2016","unstructured":"Casili G, Impellizzeri D, Cordaro M, Esposito E, Cuzzocrea S. B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury. Neurotherapeutics. 2016;13(4):880\u201394.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3821_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/cne.21149","volume":"500","author":"I Pineau","year":"2007","unstructured":"Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol. 2007;500(2):267\u201385.","journal-title":"J Comp Neurol"},{"issue":"2","key":"3821_CR18","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.18632\/oncotarget.13739","volume":"8","author":"Y Su","year":"2017","unstructured":"Su Y, Wang Y, Zhou Y, Zhu Z, Zhang Q, Zhang X, et al. Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor. Oncotarget. 2017;8(2):2719\u201330.","journal-title":"Oncotarget"},{"issue":"1","key":"3821_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12974-022-02488-w","volume":"19","author":"T Yang","year":"2022","unstructured":"Yang T, Jiang H, Luo X, Hou Y, Li A, He B, et al. Thrombin acts as inducer of proinflammatory macrophage migration inhibitory factor in astrocytes following rat spinal cord injury. J Neuroinflammation. 2022;19(1):120.","journal-title":"J Neuroinflammation"},{"key":"3821_CR20","doi-asserted-by":"crossref","unstructured":"Hao H, Hou Y, Li A, Niu L, Li S, He B, et al. HIF-1alpha promotes astrocytic production of macrophage migration inhibitory factor following spinal cord injury. CNS Neurosci Ther. 2023.","DOI":"10.1111\/cns.14300"},{"issue":"8","key":"3821_CR21","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.18632\/aging.101935","volume":"11","author":"DM Wu","year":"2019","unstructured":"Wu DM, Zheng ZH, Wang S, Wen X, Han XR, Wang YJ, et al. Association between plasma macrophage migration inhibitor factor and deep vein thrombosis in patients with spinal cord injuries. Aging. 2019;11(8):2447\u201356.","journal-title":"Aging"},{"issue":"4","key":"3821_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.apmr.2014.10.021","volume":"96","author":"M Bank","year":"2015","unstructured":"Bank M, Stein A, Sison C, Glazer A, Jassal N, McCarthy D, et al. Elevated circulating levels of the pro-inflammatory cytokine macrophage migration inhibitory factor in individuals with acute spinal cord injury. Arch Phys Med Rehabil. 2015;96(4):633\u201344.","journal-title":"Arch Phys Med Rehabil"},{"issue":"8","key":"3821_CR23","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.apmr.2013.04.004","volume":"94","author":"A Stein","year":"2013","unstructured":"Stein A, Panjwani A, Sison C, Rosen L, Chugh R, Metz C, et al. Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury. Arch Phys Med Rehabil. 2013;94(8):1498\u2013507.","journal-title":"Arch Phys Med Rehabil"},{"key":"3821_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cellsig.2019.01.006","volume":"57","author":"SS Jankauskas","year":"2019","unstructured":"Jankauskas SS, Wong DWL, Bucala R, Djudjaj S, Boor P. Evolving complexity of MIF signaling. Cell Signal. 2019;57:76\u201388.","journal-title":"Cell Signal"},{"issue":"2","key":"3821_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11011-016-9798-x","volume":"31","author":"R Meza-Romero","year":"2016","unstructured":"Meza-Romero R, Benedek G, Leng L, Bucala R, Vandenbark AA. Predicted structure of MIF\/CD74 and RTL1000\/CD74 complexes. Metab Brain Dis. 2016;31(2):249\u201355.","journal-title":"Metab Brain Dis"},{"issue":"12","key":"3821_CR26","doi-asserted-by":"publisher","first-page":"e2451333","DOI":"10.1002\/eji.202451333","volume":"54","author":"S Rubio","year":"2024","unstructured":"Rubio S, Somers V, Fraussen J. The macrophage migration inhibitory factor\/CD74 axis in traumatic spinal cord injury: lessons learned from animal and human studies. Eur J Immunol. 2024;54(12):e2451333.","journal-title":"Eur J Immunol"},{"issue":"1","key":"3821_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12974-018-1297-z","volume":"15","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Guo W, Zhu Z, Hu Y, Wang Y, Zhang X, et al. Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury. J Neuroinflammation. 2018;15(1):253.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3821_CR28","first-page":"1802","volume":"18","author":"H Zhang","year":"2023","unstructured":"Zhang H, Hu YM, Wang YJ, Zhou Y, Zhu ZJ, Chen MH, et al. Macrophage migration inhibitory factor facilitates astrocytic production of the CCL2 chemokine following spinal cord injury. Neural Regen Res. 2023;18(8):1802\u20138.","journal-title":"Neural Regen Res"},{"key":"3821_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2019.04.022","volume":"408","author":"Z Zhu","year":"2019","unstructured":"Zhu Z, Hu Y, Zhou Y, Zhang Y, Yu L, Tao L, et al. Macrophage Migration Inhibitory Factor Promotes Chemotaxis of Astrocytes through Regulation of Cholesterol 25-Hydroxylase Following Rat Spinal Cord Injury. Neuroscience. 2019;408:349\u201360.","journal-title":"Neuroscience"},{"issue":"1","key":"3821_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12974-019-1468-6","volume":"16","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhou Y, Chen S, Hu Y, Zhu Z, Wang Y, et al. Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury. J Neuroinflammation. 2019;16(1):85.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3821_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.neures.2011.07.1821","volume":"71","author":"F Wang","year":"2011","unstructured":"Wang F, Wu H, Xu S, Guo X, Yang J, Shen X. Macrophage migration inhibitory factor activates cyclooxygenase 2-prostaglandin E2 in cultured spinal microglia. Neurosci Res. 2011;71(3):210\u20138.","journal-title":"Neurosci Res"},{"issue":"3","key":"3821_CR32","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.neuroscience.2005.12.056","volume":"139","author":"M Chalimoniuk","year":"2006","unstructured":"Chalimoniuk M, King-Pospisil K, Metz CN, Toborek M. Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons. Neuroscience. 2006;139(3):1117\u201328.","journal-title":"Neuroscience"},{"issue":"3","key":"3821_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00401-008-0476-x","volume":"117","author":"Y Nishio","year":"2009","unstructured":"Nishio Y, Koda M, Hashimoto M, Kamada T, Koshizuka S, Yoshinaga K, et al. Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice. Acta Neuropathol. 2009;117(3):321\u20138.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3821_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.bbrc.2019.12.115","volume":"523","author":"D Yang","year":"2020","unstructured":"Yang D, Shu T, Zhao H, Sun Y, Xu W, Tu G. Knockdown of macrophage migration inhibitory factor (MIF), a novel target to protect neurons from parthanatos induced by simulated post-spinal cord injury oxidative stress. Biochem Biophys Res Commun. 2020;523(3):719\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3821_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.178.1.163","volume":"178","author":"H Schori","year":"2007","unstructured":"Schori H, Shechter R, Shachar I, Schwartz M. Genetic manipulation of CD74 in mouse strains of different backgrounds can result in opposite responses to central nervous system injury. J Immunol. 2007;178(1):163\u201371.","journal-title":"J Immunol"},{"issue":"2","key":"3821_CR36","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/nn505980z","volume":"9","author":"T Saxena","year":"2015","unstructured":"Saxena T, Loomis KH, Pai SB, Karumbaiah L, Gaupp E, Patil K, et al. Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury. ACS Nano. 2015;9(2):1492\u2013505.","journal-title":"ACS Nano"},{"issue":"4","key":"3821_CR37","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1021\/acsami.3c14902","volume":"16","author":"Y Gao","year":"2024","unstructured":"Gao Y, Wang K, Wu S, Wu J, Zhang J, Li J, et al. Injectable and Photocurable Gene Scaffold Facilitates Efficient Repair of Spinal Cord Injury. ACS Appl Mater Interfaces. 2024;16(4):4375\u201394.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3821_CR38","doi-asserted-by":"publisher","first-page":"873315","DOI":"10.3389\/fimmu.2022.873315","volume":"13","author":"J Fraussen","year":"2022","unstructured":"Fraussen J, Beckers L, van Laake-Geelen CCM, Depreitere B, Deckers J, Cornips EMJ, et al. Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical Parameters. Front Immunol. 2022;13:873315.","journal-title":"Front Immunol"},{"issue":"5","key":"3821_CR39","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/FOC.2008.25.11.E2","volume":"25","author":"JW Rowland","year":"2008","unstructured":"Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus. 2008;25(5):E2.","journal-title":"Neurosurg Focus"},{"issue":"10","key":"3821_CR40","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41393-019-0350-9","volume":"57","author":"R Betz","year":"2019","unstructured":"Betz R, Biering-S\u00f8rensen F, Burns SP, Donovan W, Graves DE, Guest J, et al. The 2019 revision of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)\u2014What\u2019s new? Spinal Cord. 2019;57(10):815\u20137.","journal-title":"Spinal Cord"},{"key":"3821_CR41","doi-asserted-by":"crossref","unstructured":"Ogurcov S, Shulman I, Garanina E, Sabirov D, Baichurina I, Kuznetcov M, et al. Blood serum cytokines in patients with subacute spinal cord injury: a pilot study severity. Brain Sci. 2021;11(3):322.","DOI":"10.3390\/brainsci11030322"},{"issue":"1","key":"3821_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-004-0853-z","volume":"108","author":"M Koda","year":"2004","unstructured":"Koda M, Nishio Y, Hashimoto M, Kamada T, Koshizuka S, Yoshinaga K, et al. Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats. Acta Neuropathol. 2004;108(1):31\u20136.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3821_CR43","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1002\/ctm2.272","volume":"11","author":"T Jogia","year":"2021","unstructured":"Jogia T, Lubstorf T, Jacobson E, Scriven E, Atresh S, Nguyen QH, et al. Prognostic value of early leukocyte fluctuations for recovery from traumatic spinal cord injury. Clin Transl Med. 2021;11(1):e272.","journal-title":"Clin Transl Med"},{"issue":"23\u201324","key":"3821_CR44","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1089\/neu.2022.0500","volume":"40","author":"D Morrison","year":"2023","unstructured":"Morrison D, Pinpin C, Lee A, Sison C, Chory A, Gregersen PK, et al. Profiling Immunological Phenotypes in Individuals During the First Year After Traumatic Spinal Cord Injury: A Longitudinal Analysis. J Neurotrauma. 2023;40(23\u201324):2621\u201337.","journal-title":"J Neurotrauma"},{"issue":"3","key":"3821_CR45","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.neuroscience.2008.08.021","volume":"158","author":"T Riegger","year":"2009","unstructured":"Riegger T, Conrad S, Schluesener HJ, Kaps HP, Badke A, Baron C, et al. Immune depression syndrome following human spinal cord injury (SCI): a pilot study. Neuroscience. 2009;158(3):1194\u20139.","journal-title":"Neuroscience"},{"issue":"2","key":"3821_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/10790268.2000.11753518","volume":"23","author":"MS Nash","year":"2000","unstructured":"Nash MS. Known and plausible modulators of depressed immune functions following spinal cord injuries. J Spinal Cord Med. 2000;23(2):111\u201320.","journal-title":"J Spinal Cord Med"},{"issue":"6","key":"3821_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00002060-199411000-00003","volume":"73","author":"DI Campagnolo","year":"1994","unstructured":"Campagnolo DI, Keller SE, DeLisa JA, Glick TJ, Sipski ML, Schleifer SJ. Alteration of immune system function in tetraplegics. A pilot study. Am J Phys Med Rehabil. 1994;73(6):387\u201393.","journal-title":"Am J Phys Med Rehabil"},{"issue":"7","key":"3821_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sc.2008.4","volume":"46","author":"DI Campagnolo","year":"2008","unstructured":"Campagnolo DI, Dixon D, Schwartz J, Bartlett JA, Keller SE. Altered innate immunity following spinal cord injury. Spinal Cord. 2008;46(7):477\u201381.","journal-title":"Spinal Cord"},{"issue":"7","key":"3821_CR49","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"CM Tipton","year":"2015","unstructured":"Tipton CM, Fucile CF, Darce J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16(7):755\u201365.","journal-title":"Nat Immunol"},{"issue":"4","key":"3821_CR50","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 2018;49(4):725\u201339. e6.","journal-title":"Immunity"},{"issue":"1","key":"3821_CR51","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1186\/s12967-024-05779-3","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y. Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications. J Transl Med. 2024;22(1):1002.","journal-title":"J Transl Med"},{"key":"3821_CR52","doi-asserted-by":"publisher","first-page":"153331752412385","DOI":"10.1177\/15333175241238577","volume":"39","author":"B Liu","year":"2024","unstructured":"Liu B, Luo W, Huang L, Wei C, Huang X, Liu J, et al. Migration Inhibition Factor Secreted by Peripheral Blood Memory B Cells Binding to CD74-CD44 Receptor Complex Drives Macrophage Behavior in Alzheimer\u2019s Disease. Am J Alzheimers Dis Other Demen. 2024;39:15333175241238577.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"2","key":"3821_CR53","doi-asserted-by":"publisher","first-page":"e18254","DOI":"10.1111\/jcmm.18254","volume":"29","author":"W Jin","year":"2025","unstructured":"Jin W, Chen J, Li Z, Yubiao Z, Peng H. Bayesian-optimized deep learning for identifying essential genes of mitophagy and fostering therapies to combat drug resistance in human cancers. J Cell Mol Med. 2025;29(2):e18254.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"3821_CR54","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00011-023-01791-3","volume":"72","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhang M, Jia Y, Liu W, Li S, Gao C, et al. Featured immune characteristics of COVID-19 and systemic lupus erythematosus revealed by multidimensional integrated analyses. Inflamm Res. 2023;72(9):1877\u201394.","journal-title":"Inflamm Res"},{"issue":"5","key":"3821_CR55","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s00277-025-06321-1","volume":"104","author":"J Zhang","year":"2025","unstructured":"Zhang J, Gao T, Chen S, Wu S, Mao Y, Cai D, et al. Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes. Ann Hematol. 2025;104(5):2847\u201367.","journal-title":"Ann Hematol"},{"issue":"1","key":"3821_CR56","doi-asserted-by":"publisher","first-page":"e2308174","DOI":"10.1002\/advs.202308174","volume":"12","author":"D Dai","year":"2025","unstructured":"Dai D, Li X, Zhuang H, Ling Y, Chen L, Long C, et al. Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients. Adv Sci (Weinh). 2025;12(1):e2308174.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"3821_CR57","doi-asserted-by":"publisher","first-page":"e200384","DOI":"10.1212\/NXI.0000000000200384","volume":"12","author":"P Terroba-Navajas","year":"2025","unstructured":"Terroba-Navajas P, Lu IN, Quast I, Heming M, Keller CW, Ostendorf L, et al. Single-Cell Transcriptomics Identifies a Prominent Role for the MIF-CD74 Axis in Myasthenia Gravis Thymus. Neurol Neuroimmunol Neuroinflamm. 2025;12(3):e200384.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"23","key":"3821_CR58","doi-asserted-by":"publisher","first-page":"11054","DOI":"10.1073\/pnas.90.23.11054","volume":"90","author":"DJ Lenschow","year":"1993","unstructured":"Lenschow DJ, Su GH, Zuckerman LA, Nabavi N, Jellis CL, Gray GS, et al. Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A. 1993;90(23):11054\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3821_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/85251","volume":"2","author":"AJ Coyle","year":"2001","unstructured":"Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol. 2001;2(3):203\u20139.","journal-title":"Nat Immunol"},{"issue":"11","key":"3821_CR60","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/eji.201847623","volume":"48","author":"L Rijvers","year":"2018","unstructured":"Rijvers L, Melief MJ, van der Vuurst RM, Stephant M, van Langelaar J, Wierenga-Wolf AF, et al. The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis. Eur J Immunol. 2018;48(11):1861\u201371.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3821_CR61","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1186\/ar3767","volume":"14","author":"D Frolich","year":"2012","unstructured":"Frolich D, Blassfeld D, Reiter K, Giesecke C, Daridon C, Mei HE, et al. The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression. Arthritis Res Ther. 2012;14(2):R54.","journal-title":"Arthritis Res Ther"},{"key":"3821_CR62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellsig.2018.02.010","volume":"46","author":"C Klasen","year":"2018","unstructured":"Klasen C, Ziehm T, Huber M, Asare Y, Kapurniotu A, Shachar I, et al. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF. Cell Signal. 2018;46:32\u201342.","journal-title":"Cell Signal"},{"issue":"3","key":"3821_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm0397-320","volume":"3","author":"SC Donnelly","year":"1997","unstructured":"Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med. 1997;3(3):320\u20133.","journal-title":"Nat Med"},{"key":"3821_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2407-4-34","volume":"4","author":"KL Meyer-Siegler","year":"2004","unstructured":"Meyer-Siegler KL, Leifheit EC, Vera PL. Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells. BMC Cancer. 2004;4:34.","journal-title":"BMC Cancer"},{"issue":"2","key":"3821_CR65","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1172\/JCI81937","volume":"126","author":"J Yao","year":"2016","unstructured":"Yao J, Leng L, Sauler M, Fu W, Zheng J, Zhang Y, et al. Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus. J Clin Invest. 2016;126(2):732\u201344.","journal-title":"J Clin Invest"},{"issue":"1","key":"3821_CR66","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1073\/pnas.012511599","volume":"99","author":"RA Mitchell","year":"2002","unstructured":"Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002;99(1):345\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3821_CR67","doi-asserted-by":"publisher","first-page":"e3002905","DOI":"10.1371\/journal.pbio.3002905","volume":"22","author":"B Pellegrino","year":"2024","unstructured":"Pellegrino B, David K, Rabani S, Lampert B, Tran T, Doherty E, et al. CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells. PLoS Biol. 2024;22(11):e3002905.","journal-title":"PLoS Biol"},{"key":"3821_CR68","doi-asserted-by":"crossref","unstructured":"Gao Y, Wang K, Wu Y, Wu S, Ma P, Zhang J, et al. Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury. MedComm (2020). 2025;6(3):e70099.","DOI":"10.1002\/mco2.70099"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03821-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03821-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:32:01Z","timestamp":1781649121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03821-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03821-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Medical Ethics Committee of Hospital East Limburg (B371201317091), Academic Hospital Maastricht (METC13-4-079) and the other institutional Medical Ethics Committees. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}